Proteomics Market Overview
In the coming years, the global proteomics market is projected to grow significantly on account of the technological enhancements, availability of higher funding for research, rising healthcare expenditure, increasing preference for personalized medicine, and surging prevalence of genetic diseases. Proteomics refers to the study of proteomes, which itself refers to the entire set of proteins produced by a cell or a genome.
Several instrumentation technologies are applied in this field, including spectroscopy, protein microarrays, chromatography, X-ray crystallography, surface plasmon resonance (SPR) systems, electrophoresis, and protein fractionation systems. Among these, the largest proteomics market share was held by protein microarray, historically, as it requires only a small sample to present numerous results. Other advantages of this technology are full imprint of proteins, label-free detection, and absolute and direct quantification. In the near future, protein fractionation is forecast to witness the fastest growth, due to the high resolution it offers and effective separation of various proteins in a complex structure it offers.
Protein fractionation reagents, microarray reagents, x-ray crystallography reagents, spectroscopy reagents, electrophoresis reagents, chromatography reagents, and immunoassay reagents are the various reagents used for proteome study. Among these, protein fractionation reagents are expected to experience the highest CAGR in the proteomics market, as these are helpful in making the study of complex protein structures simple, which makes research quicker as well as more efficient.
Protein research has drug discovery, clinical diagnostics, and various other applications. Historically, clinical diagnostics was the largest application in the industry, as the importance of understanding protein expression for effective diagnosis of diseases as well as for development of drugs. Among the various software and services provided by vendors, analytical laboratory services occupied the largest proteomics market size in the past, primarily because of a rise in research and development (R&D) activities taken up by governments and the major players.
Across the globe, North America currently holds the largest share in the domain, as the investments, in order to create drug design based on protein structures, are increasing as are R&D activities, requirement for advanced research tools to reproduce data, and popularity of personalized medicine. Another reason for the dominance of the region on the proteomics market is that a large number of large industry players exist here. The fastest growth in the coming years is projected to be witnessed by Asia-Pacific (APAC), as a result of the rise in investments by public and private organizations, increasing research in biotechnology, and surging awareness about personalized medicine.
Proteomics Market Dynamics
Drivers
The key reason for the proteomics market growth is the rising popularity of personalized medicine, particularly for cancer. Personalized medicine has transformed the ways in which diseases are studied, analyzed, and targeted. The Personalized Medicine Coalition published a report in 2017, which claimed that personalized treatments, drugs, and diagnostic products increased by 30% since 2006. Additionally, biotech and pharma firms, on an average, have doubled their investments in personalized medicine R&D, since the last five years, and in the next five years, they are projected to rise by another 33%.
Though genomics is currently used to develop such therapies, the study proved inefficient in predicting the diversity in the way proteins express, undergo modification, and interact, after translation. The incorporation of the proteome study results into the genomics data of individuals allows for more effective personalized medicine, thereby driving the proteomics market progress. With the increasing popularity of such treatment methods, the demand for sensitive, rapid, and effective analysis of proteins and the modifications that happen after translation, is also surging.
Opportunities
Lucrative proteomics market opportunities are being presented by the growing adoption of nanoproteomics. Nanotechnology in the field is helping tackle the challenges posed by the study of post-translational modifications (PTM), wide array of molecules, and complexities in the biology. Owing to the use of nanostructure surfaces to separate proteins, phosphoproteomics/metal-oxide nanoparticles, and analytical identification of biomarker proteins, the nanoproteomics field has rapidly emerged. These techniques, complemented by functionalized nanoparticles, nanoporous structures, polymeric nanostructures, and quantum dots, allow for the detection of proteins that are low in concentration in a given sample.
Proteomics Market Competitive Landscape
To stay ahead of the competition, the major players in the global proteomics market have undertaken partnerships and product launches. For instance, Thermo Fisher Scientific Inc. and Symphogen announced a collaboration in October 2018, allowing Symphogen to use its BioPharma Option, together with the Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) developed by Thermo Fisher, to develop, test, and verify various platform workflows, to undertake native and intact mass analysis of monoclonal antibody mixtures for treatment of numerous diseases.
The major proteomics market players are Bruker Corporation, Agilent Technologies Inc., Merck KGaA, GE Healthcare, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Waters Corporation, PerkinElmer Inc., and Luminex Corporation.
